Palmitoylethanolamide (PEA) is a member of the endocannabinoid fatty acid amides and exhibits potent anti-inflammatory and analgesic properties. Ext...
Palmitoylethanolamide (PEA) is a member of the endocannabinoid fatty acid amides and exhibits potent anti-inflammatory and analgesic properties. Extensive clinical evidence supports the pleiotropic effects of PEA, where it appears to exert it’s therapeutic effects via more than one mode of action, by modulating the endocannabinoid system in a safer and therapeutically efficacious manner.
PEA is typically poorly water-soluble which affects oral absorption and bioavailability. Micronization helps reduce large PEA particles to the micron range (<10 μm), providing a larger total surface area and enables rapid dissolution and therapeutic efficacy corroborated by preclinical evidence.
NFH Pain Relief SAP:
- Provides high quality micronized PEA for enhanced absorption, bioavailability, and efficacy.
- Helps relieve joint pain associated with osteoarthritis
SIZE/FORMAT: 120 Capsules
NPN: 80088752
Adults: Take 2-4 capsules daily or as directed by your health‑care practitioner.
May take up to two weeks to notice the beneficial effects. Take daily for a minimum of two weeks for chronic pain relief.
Contains No: Gluten, soy, wheat, eggs, dairy, yeast, citrus, preservatives, artificial colours and flavours, starch, or sugar.
*Requires practitioner recommendation
Each vegetable capsule contains:
| Palmitoylethanolamide (micronized) |
300 mg |
| Devil’s claw (Harpagophytum procumbens) extract, 5% harpagosides |
30 mg |
